Elsevier

Journal of Voice

Volume 9, Issue 2, June 1995, Pages 205-211
Journal of Voice

Gastroesophageal reflux laryngitis resistant to omeprazole therapy

https://doi.org/10.1016/S0892-1997(05)80254-1Get rights and content

Summary

Gastroesophageal reflux disease (GERD) is known to cause a variety of symptoms that lead a patient to seek otolaryngologic care. New advances in the treatment of GERD have enabled otolaryngologists to eliminate most of the signs and symptoms caused by acid reflux. Omeprazole, the most recent pharmacologic advancement, has been reported to be universally successful in controlling acid release from the stomach of patients with GERD. This report describes a series of patients with GERD for whom high-dose omeprazole therapy was not successful in completely reducing gastric acid levels of GERD symptomatology.

References (43)

  • DoddsWJ et al.

    Pathogenesis of reflux esophagitis

    Gastroenterology

    (1981)
  • SontagSJ et al.

    Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: the U.S. Multicenter Study

    Gastroenterology

    (1992)
  • SpechlerSJ

    Epidemiology and natural history of gastrooesophageal reflux disease

    Digestion

    (1992)
  • CastellDO

    Gastro-esophageal reflux disease

  • DeMeesterTR et al.

    Patterns of gastro-esophageal reflux in health and disease

    Ann Surg

    (1976)
  • DentJ et al.

    Mechanisms of sphincter incompetence in patients with symptomatic gastro-esophageal reflux

    Gastroenterology

    (1983)
  • Sataloff RT, Spiegel JR. Gastroesophageal reflux laryngitis. In: Castell DO, ed. The esophagus. 2nd ed. Boston: Little,...
  • DeplaACTM

    Gastro-esophageal reflux in patients with bronchial asthma

    Digestion

    (1989)
  • Klinkenberg-KnolEC et al.

    Treatment of reflux oesophagitis resistant to H-2 receptor antagonist

    Digestion

    (1989)
  • SachsG et al.

    Biological basis of omeprazole therapy

    J Gastroenterol Hepatol

    (1989)
  • ClissoldS et al.

    Omeprazole: a preliminary review

    Drugs

    (1985)
  • OosterhuisB et al.

    Omeprazole: pharmacology, pharmacokinetics and interactions

    Digestion

    (1989)
  • AdamsMH et al.

    Therapeutic evaluation of omeprazole

    Clin Pharm

    (1988)
  • CederbergC et al.

    Omeprazole: pharmacokinetics and metabolism in man

    Scand J Gastroenterol

    (1989)
  • RobinsonM et al.

    Effect of different doses of omeprazole on 24-hour oesophageal acid exposure in patients with gastro-esophageal reflux

    Aliment Pharmacol Ther

    (1991)
  • ChivertonSG et al.

    Omeprazole (20 mg) daily given in the morning or evening: a comparison of effects on gastric acidity, and plasma gastrin and omeprazole concentration

    Aliment Pharmacol Ther

    (1992)
  • CollenMJ et al.

    Comparison of omeprazole and ranitidine in treatment of refractory gastroesophageal reflux in patients with gastric acid hypersecretion

    Dig Dis Sci

    (1992)
  • BrunnerG et al.

    Omeprazole in the long-term management of patients with acid-related diseases resistant to ranitidine

    Scand J Gastroenterol

    (1989)
    BrunnerG et al.

    Omeprazole in the long-term management of patients with acid-related diseases resistant to ranitidine

    Scand J Gastroenterol

    (1989)
  • WalanA

    Clinical experience with omeprazole: assessment of efficacy and safety

    J Gastroenterol Hepatol

    (1989)
  • RasmussenL et al.

    Short report: a double-blind placebo-controlled trial of omeprazole on characteristics of gastric emptying in healthy subjects

    Aliment Pharmacol Ther

    (1991)
  • DahlgrenS et al.

    The effects of omeprazole and cimetidine on duodenal ulcer healing and the relief of symptoms

    Aliment Pharmacol Ther

    (1988)
  • Cited by (35)

    • Development of the Arabic version of reflux symptom index

      2012, Journal of Voice
      Citation Excerpt :

      Traditionally, otolaryngologists have considered resolution of symptoms with empiric treatment with proton pump inhibitors (PPIs) to be diagnostic of LPR. Failure to respond has been believed to indicate misdiagnosis, inadequate treatment, or resistance to treatment.3 The pH-impedance testing seems to offer the most objective data and is considered the current “gold standard,” but the accuracy of this measure has come into question.

    • Interaction of sleep disturbances and gastroesophageal reflux in chronic laryngitis

      2002, American Journal of Otolaryngology - Head and Neck Medicine and Surgery
      Citation Excerpt :

      Evidence is accumulating that reflux, the role of which in esophageal carcinoma is already known,28 is also of major etiologic importance in benign and malignant tumors of the larynx and the throat.14,16,25,29,30 It is known that 10% to 30% of patients fail to respond adequately to conventional treatment with proton pump inhibitors and prokinetic drugs, despite receiving high doses of these substances.10,12,13,31 In our patient population, this occurred in 11.1% of the cases.

    View all citing articles on Scopus
    View full text